AI in Drug Discovery, Blog Posts, Science Blogs, Science content
Beyond the hype: What pharma really has to gain from de novo antibodies
Media Highlights
WorkLife: The Rise of the Chief AI Officer
Press Releases
Absci Expands in Europe with Launch of New Innovation Center and Additional Senior Leadership in Switzerland
Forbes: Absci Takes Its Generative AI Antibody Design Platform To Europe
MIT: AI is dreaming up drugs that no one has ever seen. Now we’ve got to see if they work.
